Marek Borský

877 citations
39 papers · 743 · h-index 16

Impact in

  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 10%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research

Papers in

    • Chronic Lymphocytic Leukemia Research 23
    • Chronic Myeloid Leukemia Treatments 7
    • Acute Myeloid Leukemia Research 4

Marek Borský

34 papers receiving 726 citations

Peers

Marek Borský
Comparison fields: 5 of 55
  • Genetics 269
  • Hematology 141
  • Pathology and Forensic Medicine 159
  • Nutrition and Dietetics 122
  • Immunology 158
Replace Kairen Kukalizch with:
Kairen Kukalizch United Kingdom
Andreas Lietz Germany
Kanteti V. S. Prasad United States
T Umiel United States
Heather Glaser United States
Takeshi Ariyama Japan
Andrzej J. Jakubowiak United States
Sai Juan Chen France
Damien Grapton Canada
Christiane Duponchel France
Marek Borský relative to Kairen Kukalizch United Kingdom Kairen Kukalizch's profile →
Citations per field
00.5×2×4×6×7.1×
Kairen Kukalizch · 1×
Citations per year

Countries citing papers authored by Marek Borský

Since Specialization
Citations

This map shows the geographic impact of Marek Borský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Borský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Borský more than expected).

Fields of papers citing papers by Marek Borský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Borský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Borský. The network helps show where Marek Borský may publish in the future.

Co-authors

The 25 scholars most cited alongside Marek Borský, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marek Borský Line = papers co-authored together Marek Borský links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2005123
2 201696
3 201286
4 202152
5 201552
6 201634
7 201830
8 202129
9 200925
10
Telomerase as a diagnostic and predictive marker in colorectal carcinoma.
200423
11 201923
12 201621
13 201719
14 201318
15
Changes in telomerase activity, expression and splicing in response to differentiation of normal and carcinoma colon cells.
200318
16 201018
17 201314
18 201410
19 200810
20 201610

About Marek Borský

Marek Borský is a scholar working on Genetics, Hematology, Immunology, Pathology and Forensic Medicine and Molecular Biology, having authored 39 papers that have together received 743 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (4 papers), Cancer-related Molecular Pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Genetics (269 citations), Hematology (141 citations), Pathology and Forensic Medicine (159 citations), Nutrition and Dietetics (122 citations) and Immunology (158 citations). Marek Borský has collaborated with scholars based in Czechia, United States and Slovakia. Frequent co-authors include Libor Kozák, Jiri Mayer, Michael Doubek, Šárka Pospı́šilová, Yvona Brychtová, Martin Trbušek, Marek Mráz, Kateřina Amruz Černá, Karla Plevová and Boris Tichý. Their work appears in journals such as Blood, Leukemia, British Journal of Haematology, Leukemia Research and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact